Ruthsarian
Home
Sitemap
Q & A
Notice Board
PhEpi & PhV activities
Research Funding
Conferences & meetings
Recruitment
Links
Contact Us
Links to Studies
Status
Official Title
Lead Investigator
Last Updated
Finalised
Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries, using a cohort approach in children and adults with a full primary Covid-19 vaccination regimen
Dr Elisa MartÃn Merino
24/04/2023
Finalised
Background rates of Adverse Events of Special Interest for monitoring COVID-19 vaccines
Professor Miriam Sturkenboom
09/01/2023
Finalised
Coverage of COVID-19 vaccines in electronic healthcare databases: a protocol template from the ACCESS project
Professor Miriam Sturkenboom
09/01/2023
Finalised
ACCESS template protocol for safety of COVID-19 vaccines
Professor Miriam Sturkenboom
09/01/2023
Finalised
Cohort monitoring of Adverse Events of Special Interest and COVID-19 diagnoses prior to and after COVID-19 vaccination
Professor Miriam Sturkenboom
09/01/2023
Finalised
Impact of EU label changes and revised pregnancy prevention programme for oral retinoid containing medicinal products: utilization and prescribing trends
Dr Miriam Sturkenboom
09/11/2022
Finalised
Strengthening Use of Real-World Data in Medicines Development: Metadata for Data Discoverability and Study Replicability
Dr Susana Perez-Gutthann
18/10/2022
Finalised
ACCESS template protocols for effectiveness of COVID-19 vaccines
Professor Miriam Sturkenboom
02/02/2021
Finalised
Testing new approaches to monitoring benefit/risk with pertussis vaccines as test case: Incidence rates of pertussis and pertussis related outcomes of whole-cell pertussis and acellular pertussis vaccines in pre-school children
Professor Miriam Sturkenboom
27/11/2017
Ongoing
A post-authorisation/post-marketing observational study to evaluate the association between exposure to AZD1222 and safety concerns using existing secondary health data sources (COVID-19)
Dr Cristina Rebordosa
12/05/2023
Ongoing
An Observational Post-Authorization Safety Study to Assess the Safety of Ad26.COV2.S Using European Healthcare Data through VAC4EU (COVID-19)
Dr Fariba Ahmadizar
08/05/2023
Ongoing
Rapid Safety Assessment of SARS-CoV-2 vaccines in EU Member States using electronic health care datasources
Professor Miriam Sturkenboom
09/01/2023
Ongoing
Implementation of EU risk minimisation measures for medicinal products in clinical guidelines
Dr Helga Gardarsdottir
23/11/2022
Ongoing
CONSIGN study: COVID-19 infection and medicines in pregnancy - a multinational registry based study
Professor Hedvig Nordeng
16/08/2022
Ongoing
COVID-19 infections and medicines in pregnancy- the INOSS collaboration
Professor Kitty Bloemenkamp
29/04/2021
Ongoing
A Real World Evidence prospective cohort study in the management of metastatic colorectal cancer: a clinical and patient perspective
Professor Miriam Koopman
25/03/2021
Planned
Description of international collaboration in the area of medicines use and effects in COVID-19 affected pregnancies (CONSIGN-International))
Professor Miriam Sturkenboom
29/09/2022
Planned
Cohort Event Monitoring of safety of COVID-19 vaccines in special populations (pregnant and lactating women, children and adolescents, immunocompromised, people with history of allergy, people with prior SARS-CoV-2 infection)
Professor Gianluca Trifirò
15/06/2022
Planned
Exposure and coverage to routine schedule vaccines in different EU countries
Professor Miriam Sturkenboom
02/02/2019
News
About Us
ENCePP Documents
Training in PhEpi and PV
Code of Conduct
Standards & Guidances
ENCePP Study Seal
Public Consultation
Glossary of terms
Resources Database
Partners forum
EU PAS Register
About EU PAS Register